Enhancing Scleral Lens Fit With Advanced Imaging
Launched by FERNANDO FERNANDEZ VELAZQUEZ · Dec 20, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This prospective, single-center clinical trial aims to refine the process of fitting scleral lenses by utilizing advanced imaging technologies to enhance the precision and predictability of lens adaptations for individuals with complex corneal conditions. Conducted at Centro Fernández in Madrid, Spain, the study focuses on patients who have historically struggled with standard contact lens solutions due to conditions such as keratoconus, post-surgical corneal irregularities, and severe dry eye syndrome.
Study Objectives:
The primary objective of the study is to determine if detailed sagit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years and older. Diagnosed with keratoconus, post-corneal transplant irregularities, or severe dry eye disease, which are indicated for scleral lens usage.
- • Previous intolerance or inability to use other types of contact lenses such as soft or rigid gas-permeable lenses.
- • Willing and able to comply with scheduled visits, treatment plan, and other study procedures.
- • Adequate ocular health suitable for contact lens wear, except for conditions being treated in the study.
- • Ability to give informed consent.
- Exclusion Criteria:
- • Under 18 years of age. Active ocular infection or inflammation. History of herpetic keratitis. Severe allergies or contraindications to any component of the scleral lenses or imaging dyes used in the study.
- • Any condition which, in the opinion of the investigator, may interfere with safe participation in the study or adherence to study procedures.
- • Participation in another simultaneous clinical trial that might confound the results of the current study.
- • Pregnant or breastfeeding women.
About Fernando Fernandez Velazquez
Fernando Fernandez Velazquez is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, he leads initiatives that prioritize ethical standards and regulatory compliance. His extensive experience in clinical development and collaboration with multidisciplinary teams positions him as a key contributor in the pharmaceutical and biotechnology sectors. Through strategic partnerships and a passion for scientific discovery, Fernandez aims to facilitate the successful translation of research into effective treatments, ultimately enhancing the quality of care for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported